JAFRON(SZ:300529) Sou Hu Cai Jing·2025-08-14 14:14Group 1 - The core viewpoint of the news is that Jianfan Biological Technology Group Co., Ltd. has experienced a decline in its financial performance, with significant decreases in revenue and net profit in the latest quarterly report [1] - As of August 14, 2025, Jianfan Biological's stock closed at 23.15 yuan, down 2.94%, with a trading volume of 113,300 hands and a transaction amount of 266 million yuan [1] - The company's latest quarterly report shows total operating revenue of 548 million yuan, a year-on-year decrease of 26.40%, and a net profit attributable to shareholders of 189 million yuan, a year-on-year decrease of 33.71% [1] Group 2 - The company has made significant investments, with a total of 17 external investments and participation in 543 bidding projects [2] - Jianfan Biological holds 95 trademark registrations and 379 patent registrations, indicating a strong focus on intellectual property [2] - The company has obtained 305 administrative licenses, reflecting its compliance and operational capabilities in the pharmaceutical manufacturing industry [2]